HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michiaki Kubo Selected Research

protein kinase C eta

1/2011[Genome-wide association study for ischemic stroke based on the Hisayama study].
2/2007A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michiaki Kubo Research Topics

Disease

36Neoplasms (Cancer)
01/2022 - 06/2006
34Breast Neoplasms (Breast Cancer)
01/2020 - 05/2008
14Rheumatoid Arthritis
01/2019 - 10/2008
13Hypertension (High Blood Pressure)
01/2022 - 01/2002
12Infections
01/2018 - 07/2006
9Type 2 Diabetes Mellitus (MODY)
12/2021 - 09/2008
9Prostatic Neoplasms (Prostate Cancer)
01/2020 - 01/2011
7Drug-Related Side Effects and Adverse Reactions
01/2022 - 03/2011
7Stroke (Strokes)
11/2020 - 01/2006
7Asthma (Bronchial Asthma)
01/2018 - 07/2012
7Chronic Hepatitis C
06/2014 - 09/2010
6Testicular Neoplasms (Testicular Cancer)
10/2019 - 01/2017
6Gout
10/2019 - 02/2013
6Stomach Neoplasms (Stomach Cancer)
01/2018 - 04/2005
5Cardiovascular Diseases (Cardiovascular Disease)
12/2021 - 09/2004
5Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 04/2012
5Coronary Artery Disease (Coronary Atherosclerosis)
11/2020 - 01/2019
5Neutropenia
01/2019 - 05/2008
5Obesity
01/2019 - 01/2006
5Ischemic Stroke
01/2018 - 01/2006
4Hypersensitivity (Allergy)
11/2019 - 03/2011
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2019 - 01/2012
4Major Depressive Disorder (Major Depressive Disorders)
01/2019 - 08/2014
4Peripheral Nervous System Diseases (PNS Diseases)
10/2017 - 09/2012
4Inflammation (Inflammations)
01/2017 - 09/2010
4Dyslipidemias (Dyslipidemia)
10/2016 - 07/2008
4Carcinogenesis
01/2016 - 01/2011
4Disease Susceptibility (Diathesis)
05/2014 - 02/2003
4Chronic Renal Insufficiency
07/2013 - 01/2012
4Glucose Intolerance
09/2010 - 04/2003
4Proteinuria
07/2007 - 04/2003
3Thrombocytopenia (Thrombopenia)
01/2022 - 01/2016
3Schizophrenia (Dementia Praecox)
01/2022 - 02/2013
3Myocardial Infarction
11/2020 - 01/2018
3Genetic Predisposition to Disease (Genetic Predisposition)
01/2019 - 02/2016
3Neoplasm Metastasis (Metastasis)
01/2019 - 06/2014
3Alzheimer Disease (Alzheimer's Disease)
07/2018 - 06/2011
3T-Cell Leukemia (Leukemia, T Cell)
01/2018 - 03/2012
3Leukemia
01/2018 - 01/2012
3Hypercholesterolemia
10/2017 - 09/2004
3Coronary Disease (Coronary Heart Disease)
06/2017 - 07/2008
3Atrial Fibrillation
06/2017 - 04/2014
3Endometriosis
01/2017 - 08/2010
3Liver Neoplasms (Liver Cancer)
01/2017 - 05/2012
3Diabetes Mellitus
04/2016 - 01/2012

Drug/Important Bio-Agent (IBA)

17Pharmaceutical PreparationsIBA
12/2021 - 01/2008
16Proteins (Proteins, Gene)FDA Link
11/2019 - 01/2002
14Biological ProductsIBA
12/2021 - 01/2008
12DNA (Deoxyribonucleic Acid)IBA
01/2022 - 05/2010
12Biomarkers (Surrogate Marker)IBA
01/2021 - 10/2010
11Aromatase InhibitorsIBA
10/2019 - 11/2010
11CholesterolIBA
03/2017 - 04/2003
10TamoxifenFDA LinkGeneric
01/2020 - 05/2008
8LipidsIBA
12/2021 - 02/2003
7Amino AcidsFDA Link
11/2019 - 07/2014
7CytokinesIBA
01/2019 - 02/2003
6Bevacizumab (Avastin)FDA Link
01/2021 - 01/2012
6Hormones (Hormone)IBA
01/2020 - 03/2010
6Cytochrome P-450 CYP2D6 (CYP2D6)IBA
01/2020 - 05/2008
6Estrogen ReceptorsIBA
10/2019 - 04/2013
6Uric Acid (Urate)IBA
10/2019 - 02/2013
6Glucose (Dextrose)FDA LinkGeneric
01/2019 - 09/2002
6HLA-DRB1 Chains (HLA DRB1)IBA
12/2017 - 12/2009
6Selective Estrogen Receptor Modulators (SERM)IBA
08/2017 - 11/2011
6Estrogens (Estrogen)FDA Link
07/2017 - 03/2012
6Genetic Markers (Genetic Marker)IBA
04/2014 - 07/2010
5Antihypertensive Agents (Antihypertensives)IBA
01/2022 - 07/2002
5Cisplatin (Platino)FDA LinkGeneric
01/2019 - 08/2013
5Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 09/2012
5P-2 (P 2)IBA
10/2017 - 09/2011
5InterferonsIBA
11/2016 - 09/2010
5Ribavirin (Virazole)FDA LinkGeneric
06/2014 - 09/2010
4CalciumIBA
05/2022 - 07/2008
4LDL CholesterolIBA
12/2021 - 02/2009
4Hemoglobins (Hemoglobin)IBA
01/2019 - 02/2008
4Long Noncoding RNAIBA
01/2019 - 01/2011
4GemcitabineFDA Link
01/2019 - 01/2012
4Insulin (Novolin)FDA Link
01/2019 - 09/2002
4AntigensIBA
01/2018 - 10/2011
4HDL CholesterolIBA
01/2015 - 08/2003
4Triglycerides (Triacylglycerol)IBA
09/2014 - 08/2003
4EnzymesIBA
09/2013 - 05/2008
3Vitamin DFDA LinkGeneric
05/2022 - 01/2018
3Metformin (Glucophage)FDA LinkGeneric
12/2021 - 10/2010
3Retinaldehyde (Retinal)IBA
01/2021 - 11/2016
34-hydroxy-N-desmethyltamoxifenIBA
01/2020 - 05/2008
3HLA-DQ Antigens (HLA-DQ)IBA
11/2019 - 10/2011
3ORALIT (ORS)IBA
10/2019 - 04/2016
3PlatinumIBA
10/2019 - 08/2013
3Peptides (Polypeptides)IBA
09/2019 - 01/2012
3Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
01/2019 - 08/2014
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2018 - 03/2017
3Anticonvulsants (Antiepileptic Drugs)IBA
01/2018 - 03/2011
3Carbamazepine (Tegretol)FDA LinkGeneric
01/2018 - 03/2011
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2017 - 01/2008
3Docetaxel (Taxotere)FDA Link
10/2016 - 05/2008
3Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
06/2016 - 06/2011

Therapy/Procedure

45Therapeutics
01/2022 - 05/2003
11Drug Therapy (Chemotherapy)
01/2021 - 05/2008
3Precision Medicine
11/2019 - 05/2014